BUY IPCA Laboratories Limited — IDBI Capital

Entry₹1,975Stated
Target₹2,035
Total upside +3.04% (call closed)
Stop loss₹1,945-1.52% risk
Exit₹1,94515 Sept 2026, 2:00 pm
Stop-loss hit-1.52%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026
4 supporting0 opposing
Supports the BUY call (4)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Sept · 1w ago

Krebs Biochemicals భారీ నష్టం.. Ipca Labs తో విలీనానికి గ్రీన్ సిగ్నల్!

NewsGoogle News·4 Sept · 2w ago

(opens in new tab)

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 3w ago

(opens in new tab)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·18 Aug · 4w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.